gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE American · XTNTHealthcareSurgical Instruments

Xtant Medical Holdings, Inc. (XTNT)

$0.2960+6.47%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$0.28▼ 65.74% in range
Nov 3, 2025Low $0.28 · High $0.81Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Xtant Medical Holdings closed at $0.30 on Nov 4, up 6.47%, 63.5% below its 52-week closing high. Volume of 190.6K shares was 1.98× its 20-day average (above normal).

Split-adjusted performance: -7.7% over one month, -48.7% over six months, -63.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $23.03M, down 35.0% from a year earlier, with a net margin of -40.9%.

Short interest was 300.5K shares at the Oct 15 settlement, up 109.3% from the prior report (0.6% of float, 3.3 days to cover).

Market cap$41.5M140.3M shares
Revenue · quarter$23.0M−35.0% YoY
Diluted EPS$-0.07−450.0% YoY
P/E · TTM—P/S 0.4×
Net margin-40.9%Gross 57.9%
Dividend yieldNone
52-week range0.28 – 0.81−63.5% from high
Volume190.6K1.98× 20-day avg
Volatility · 60d69.4%Annualised
Short % of float0.6%3.3 days to cover
Net cash-$13.2MCash $9.9M
Next earnings—Not scheduled
Split-adjusted performance
1W +3.5%1M −7.7%3M −33.1%6M −48.7%YTD −62.2%1Y −63.5%3Y −73.3%5Y −75.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum23
Revenue growth3
Net margin34
Value (low P/E)—
Size29

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short300.5K+109.3% vs prior
Days to cover3.3Settled Oct 15
% of float0.6%
Short vol. 10d43.6%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
XTNTXtant Medical Holdings$0.2960+6.47%−48.7%−35.0%−40.9%—$41.5M
CVRXCVRx$1.58+14.49%−77.7%+15.6%−89.4%—$42.1MCompare
TELATELA Bio$0.8378+4.46%−15.4%−4.5%−58.4%—$37.8MCompare
NSPRInspireMD$0.7810+18.71%−32.7%−0.4%−808.8%—$36.6MCompare
NEPHNephros$3.25+0.31%+0.9%+36.2%19.9%20.3$35.3MCompare
MDAISpectral AI$1.53+2.00%−31.1%−30.4%−118.5%—$49.2MCompare
SNWVSANUWAVE Health$5.73−3.37%−64.0%−3.1%−7.0%3.4$49.3MCompare
DXRDaxor$8.91+2.44%−12.1%+2.3%−403.2%—$52.0MCompare
SRTSSensus Healthcare$3.25−1.07%−20.5%−68.7%−382.1%—$53.5MCompare

News about Xtant Medical Holdings

All news →

No recent articles focused on Xtant Medical Holdings.

Quick answers

What does Xtant Medical Holdings do?
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine.
What is XTNT's market cap?
$41.53M, based on the Nov 4 close of $0.30.
Does Xtant Medical Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of XTNT is sold short?
300.5K shares, 0.6% of float, as of Oct 15, 2026.
What sector is XTNT in?
Healthcare, in the Surgical Instruments industry.

About Xtant Medical Holdings

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

HQ: Belgrade, MT151 employeesListed Jan 31, 2007xtantmedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology